Thomas Schuetz is the founder of Compass Therapeutics. Compass Therapeutics has raised $61M in total funding. Latest round: Series B.
Thomas Schuetz is the Co-Founder, CEO, and Vice Chairman of the Board at Compass Therapeutics, a clinical-stage oncology-focused biopharmaceutical company. He was appointed President and CEO effective May 28, 2024. As CEO, he also serves as a Director and has acquired shares of the company's common stock.
Full founder directory · Investor directory · Company funding database · Fundraising library